Sterling Capital Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$4.15K	Buy	821 +556	+210%	+$2.81K	﹤0.01%	2611
2025 Q1	$1.4K	Buy	265 +15	+6%	+$79	﹤0.01%	2703
2024 Q4	$1.69K	Buy	250 +12	+5%	+$81	﹤0.01%	2824
2024 Q3	$1.57K	Buy	+238	New	+$1.57K	﹤0.01%	2310